Multiple sclerosis patients with severe walking disability have clinically meaningful improvements in walking speed with prolonged-release fampridine

被引：0
|
作者：
Hartung, H. P.
Goodman, A.
Putzki, N.
机构：
来源：
JOURNAL OF NEUROLOGY | 2011年 / 258卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：260 / 261
页数：2
相关论文
共 50 条
  • [41] Walking improvements with nabiximols in patients with multiple sclerosis
    G. Coghe
    M. Pau
    F. Corona
    J. Frau
    L. Lorefice
    G. Fenu
    G. Spinicci
    E. Mamusa
    L. Musu
    S. Massole
    R. Massa
    M. G. Marrosu
    E. Cocco
    Journal of Neurology, 2015, 262 : 2472 - 2477
  • [42] Walking improvements with nabiximols in patients with multiple sclerosis
    Coghe, G.
    Pau, M.
    Corona, F.
    Frau, J.
    Lorefice, L.
    Fenu, G.
    Spinicci, G.
    Mamusa, E.
    Musu, L.
    Massole, S.
    Massa, R.
    Marrosu, M. G.
    Cocco, E.
    JOURNAL OF NEUROLOGY, 2015, 262 (11) : 2472 - 2477
  • [43] Prolonged-release fampridine shows consistent efficacy across sub-groups of multiple sclerosis patients
    Stourac, P.
    Putzki, N.
    JOURNAL OF NEUROLOGY, 2012, 259 : S152 - S153
  • [44] Cost-effectiveness review of prolonged release fampridine in managing walking impairment in a population with advanced multiple sclerosis
    Garzo, N. Caldas
    Marceniuk, G.
    Pickering, K.
    Johnson, J.
    Ahktar, S.
    Farrell, R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 828 - 829
  • [45] The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis
    Learmonth, Yvonne C.
    Dlugonski, Deirdre D.
    Pilutti, Lara A.
    Sandroff, Brian M.
    Motl, Robert W.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (13) : 1784 - 1791
  • [46] Walking Disability Index for multiple sclerosis patients
    Mutluay, F. K.
    Siva, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 714 - 714
  • [47] Walking, quality of life, and safety with prolonged-release fampridine treatment in clinical practice: Interim results of the liberate study
    Schmidt, S.
    Oschmann, P.
    Neau, J. P.
    Castelnovo, G.
    Wang, P.
    Barbato, L.
    Mahadavan, L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E21 - E21
  • [48] Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE
    Hupperts, Raymond
    Gasperini, Claudio
    Lycke, Jan
    Ziemssen, Tjalf
    Feys, Peter
    Xiao, Shan
    Acosta, Carlos
    Koster, Thijs
    Hobart, Jeremy
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2022, 15
  • [49] Multiple sclerosis Slow-release Fampridine improved walking ability by every third
    Schindler, Birgit
    PSYCHOPHARMAKOTHERAPIE, 2009, 16 (05): : 221 - 222
  • [50] Sustained-release fampridine consistently improves walking speed and leg strength in multiple sclerosis: a phase 3 trial
    Goodman, Andrew D.
    Schwid, Steven R.
    Brown, Theodore R.
    Krupp, Lauren B.
    Schapiro, Randall T.
    Marinucci, Lawrence N.
    Cohen, Ron
    Blight, Andrew R.
    MULTIPLE SCLEROSIS, 2008, 14 : S298 - S298
12345